Status:
COMPLETED
AQCS for Detection of Early Cancer and Precancerous Lesions on Upper Gastrointestinal Tract
Lead Sponsor:
Shandong University
Collaborating Sponsors:
Binzhou Medical University
Shengli Oilfield Hospital
Conditions:
Esophagogastroduodenoscopy
Eligibility:
All Genders
40-80 years
Phase:
NA
Brief Summary
The purpose of our study was to assess the performance of esophagogastroduodenoscopy automatic quality-control system in real-time quality control of EGD.
Detailed Description
Investigators developed a real-time quality control system of esophagogastroduodenoscopy(EGD) named EGD automatic quality-control system (AQCS). Investigators carried a prospective multicenter randomi...
Eligibility Criteria
Inclusion
- Patients aged 40-80 years old
- Patients scheduled for white light EGD examination with anaesthesia
- American Society of Anesthesiology risk class 1, 2 or 3
Exclusion
- Patients with known advanced esophageal or gastric cancer
- Patients with a history of esophageal or gastric surgery
- Patients scheduled for therapeutic EGD
- Patients with stenosis or obstruction of upper gastrointestinal tract
- Patients with a history of serious anesthesia-related complications
- Patients in pregnancy or lactation phase
- Patients refused to sign the informed consent
Key Trial Info
Start Date :
January 16 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
1840 Patients enrolled
Trial Details
Trial ID
NCT04720924
Start Date
January 16 2021
End Date
December 31 2023
Last Update
May 29 2024
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Binzhou Medical University Hospital
Binzhou, Shandong, China
2
Linyi People's Hospital
Dezhou, Shandong, China
3
Central Hospital of Shengli Oilfield
Dongying, Shandong, China
4
Qilu Hospital of Shandong University
Jinan, Shandong, China, 250012